By Michelle Bodian, Sam Kovach-Orr, Bridgette Nikisher
Dec 16, 2022
Draft regulations to implement New York's Marijuana Regulation and Taxation Act have been published. While the draft regulations are over 280 pages, we summarized ten key items that will most directly impact hopeful and existing New York cannabis businesses.
By Michelle Bodian, Casey Leaver
Dec 2, 2022
In an important policy change affecting Massachusetts marijuana operators, MDAR now allows the use of pesticides on marijuana plants, provided conditions are met.
By Catie Wightman, Michelle Bodian
Nov 30, 2022
On November 21, 2022, the FDA issued five warning letters to companies selling CBD, Delta-8, and other hemp products for humans and pets.
By Yolanda Clarke, Jamie Greenwood
Nov 16, 2022
In another exciting step towards implementing psilocybin services, the Oregon Psilocybin Services Section issued updated proposed rules under the Oregon Psilocybin Services Act this month, making significant changes to the previous iteration. Make your voices heard! The public comment period is open through November 21, 2022.
By Jen Flanagan, Sam Kovach-Orr, Meg Nash, Bridgette Nikisher
Nov 16, 2022
Widespread support for allowing cannabis retail sales in Rhode Island municipalities significantly expands opportunities for potential applicants seeking to obtain one of the 24 cannabis retail licenses expected to be available in 2023. Read this article for insight into what to expect next and how to prepare.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.
